Intellectual property (IP) assets have come into the spotlight with the passage of the America Invents Act, the new U.S. Patent law signed by President Obama in September 2011. In light of the first-inventor-to-file and other provisions, business owners need to take a boots-on-the-ground approach in order to secure an IP position in the marketplace.
You've scoured your IP ideas, but you don't have anything? George Carrera, Jr., registered patent agent at Amin Talati in Chicago, will speak about effective methods to develop IP with the goal of monetizing a total corporate assets portfolio at the Chicago Section IFT dinner meeting and AACT Suppliers’ Night Monday, April 8 in Elmhurst, IL. Carrera will focus on patent requirements for nutrition, dietary supplements, and functional foods as well as strategies and costs.
With over 12 years of experience in patent law in-house in pharma and at private law firms, Carrera's practice is primarily focused on IP in the chemical and pharmaceutical arts. Currently, Carrera is actively involved in the preparation and prosecution of U.S. and foreign patent applications in the chemical, pharmaceutical, nutritional, food science and allied arts.
“For business, the outlook for the 21st century is a new beginning,” says Carrera. “The current marketplace in dietary supplements and functional foods is lucrative, yet competitive, and entrepreneurs intent upon adapting during economic downturns yet maintaining proper investment ratios need to consider developing their own patent portfolio.”
Carrera advises biotechnology, food, drug, medical device, and nutritional and dietary supplement companies regarding patentability, and assists clients to develop and maintain patent rights through the management and maintenance of patent portfolios. He also has experience assisting chemical and pharmaceutical clients in areas of import compliance, including advising on tariff classifications.
Carrera's technical background includes more than 15 years of research experience in pharmaceuticals, agrochemicals, and polymers. His core area of expertise is in organic chemistry, including proficiency in synthetic organic methodology. He has authored or co-authored numerous scientific articles in the synthetic organic and medicinal fields, and is a co-inventor on seven U.S. patents.
For more information about IP strategies and the event contact Rakesh Amin, LL.M.,
R. Ph., managing partner with Amin Talati at 312.327.3382.